PIM
Platinum Investment Management Portfolio holdings
AUM
$1.5B
This Quarter Return
-4.65%
1 Year Return
+16.62%
3 Year Return
+100.57%
5 Year Return
+187.54%
10 Year Return
+422.09%
AUM
$1.73B
AUM Growth
+$1.73B
(+1.4%)
Cap. Flow
+$120M
Cap. Flow
% of AUM
6.96%
Top 10 Holdings %
Top 10 Hldgs %
64.87%
Holding
130
New
15
Increased
46
Reduced
33
Closed
15
Top Buys
| 1 |
UBS Group
UBS
|
$132M |
| 2 |
Merck
MRK
|
$92.9M |
| 3 |
AbbVie
ABBV
|
$87.7M |
| 4 |
Lam Research
LRCX
|
$82M |
| 5 |
Valaris
VAL
|
$56.5M |
Top Sells
| 1 |
Nice
NICE
|
$68.8M |
| 2 |
Lamb Weston
LW
|
$67M |
| 3 |
Intercontinental Exchange
ICE
|
$64.6M |
| 4 |
Pinduoduo
PDD
|
$46.7M |
| 5 |
Baxter International
BAX
|
$44M |
Sector Composition
| 1 | Financials | 22.28% |
| 2 | Technology | 16.49% |
| 3 | Energy | 15.11% |
| 4 | Healthcare | 14.95% |
| 5 | Industrials | 11.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Recursion Pharmaceuticals
RXRX
$2.04B
| $2.09M | 0.12% | 395,954 -337,057 | -46% | -$1.78M |
|
|
SWTX
52
DELISTED
SpringWorks Therapeutics
SWTX
| $2.06M | 0.12% | 46,671 -224 | -0.5% | -$9.89K |
|
53
ProQR Therapeutics
PRQR
$237M
| $2.05M | 0.12% | 1,538,247 | – | – |
|
54
Gossamer Bio
GOSS
$562M
| $1.9M | 0.11% | 1,731,355 -1,448,940 | -46% | -$1.59M |
|
55
Arista Networks
ANET
$172B
| $1.68M | 0.1% | +21,690 | New | +$1.68M |
|
56
Cadence Design Systems
CDNS
$95.5B
| $1.61M | 0.09% | 6,337 +889 | +16% | +$226K |
|
57
PTC
PTC
$25.6B
| $1.52M | 0.09% | 9,808 +1,353 | +16% | +$210K |
|
58
Synopsys
SNPS
$112B
| $1.42M | 0.08% | 3,317 | – | – |
|
59
MeiraGTx Holdings
MGTX
$587M
| $1.41M | 0.08% | 208,308 -41,692 | -17% | -$283K |
|
60
Immatics
IMTX
$619M
| $1.41M | 0.08% | 311,722 | – | – |
|
61
AC Immune
ACIU
$205M
| $1.38M | 0.08% | 739,342 -212,727 | -22% | -$398K |
|
|
MBX
62
MBX Biosciences, Inc. Common Stock
MBX
$507M
| $1.37M | 0.08% | 185,932 +23,842 | +15% | +$176K |
|
63
Amphenol
APH
$133B
| $1.35M | 0.08% | 20,632 +12,158 | +143% | +$797K |
|
64
TORM
TRMD
$2.13B
| $1.31M | 0.08% | 80,000 -72,439 | -48% | -$1.18M |
|
65
Structure Therapeutics
GPCR
$1.11B
| $1.3M | 0.08% | 74,900 | – | – |
|
66
Arrowhead Research
ARWR
$3.05B
| $1.25M | 0.07% | 98,409 +9,984 | +11% | +$127K |
|
67
Applied Materials
AMAT
$128B
| $1.25M | 0.07% | 8,620 +1,084 | +14% | +$157K |
|
68
Arcus Biosciences
RCUS
$1.13B
| $1.21M | 0.07% | 153,783 | – | – |
|
69
Autodesk
ADSK
$67.3B
| $1.14M | 0.07% | 4,336 | – | – |
|
70
Adobe
ADBE
$151B
| $1.06M | 0.06% | +2,769 | New | +$1.06M |
|
|
DRUG
71
Bright Minds Biosciences
DRUG
$276M
| $1.02M | 0.06% | +28,308 | New | +$1.02M |
|
72
Coupang
CPNG
$52.1B
| $999K | 0.06% | 45,541 +9,430 | +26% | +$207K |
|
73
Aura Biosciences
AURA
$389M
| $951K | 0.06% | 162,358 | – | – |
|
74
Petrobras Class A
PBR.A
$73.9B
| $929K | 0.05% | +71,252 | New | +$929K |
|
75
Booking.com
BKNG
$181B
| $921K | 0.05% | 200 | – | – |
|